CPRX - Catalyst Pharmaceuticals' (CPRX) CEO Pat McEnany on Q1 2019 Results - Earnings Call Transcript
Catalyst Pharmaceuticals, Inc. (CPRX)
Q1 2019 Earnings Conference Call
May 13, 2019 8:30 AM
Company Participants
Alicia Grande – Chief Financial Officer
Pat McEnany – Chairman and Chief Executive Officer
Dan Brennan – Chief Commercial Officer
Steve Miller – Chief Operating Officer and Chief Scientific Officer
Conference Call Participants
Charles Duncan – Cantor Fitzgerald
Joe Catanzaro – Piper Jaffray
Edward Nash – SunTrust Robinson Humphrey
Leland Gershell – Oppenheimer and Company
Presentation
Operator
Greetings. Welcome to Catalyst Pharmaceuticals First Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode.